Brii biosciences is a biotechnology company developing therapies to address some of the world’s most common public health challenges where patients experience high unmet medical needs, limited choice and significant social stigmas. 2137.hk) is a biotechnology company developing therapies to address major public health challenges where patients experience high unmet medical needs, limited choice and significant social stigmas.
腾盛博药在2025年EASL大会上公布了其正在进行的ENSURE 2期研究的最新突破数据，表明BRII-179在促进更高的HBsAg清除方面的作用 Brii biosciences limited (“brii bio”, stock code Brii biosciences is a biotechnology company developing therapies to address major public health challenges where patients experience high unmet medical needs, limited choice and significant social stigmas.
